Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04413279 · ClinicalTrials.gov registry record · Phase 4
Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease
A Phase 4 study of Dry Eye Syndromes, sponsored by Eye Surgeons of Indiana.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04413279 is a Phase 4 study of Dry Eye Syndromes that has completed, run by Eye Surgeons of Indiana. The registered enrollment target is 20 participants, below the 413-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04413279, a Phase 4 study of Dry Eye Syndromes, has completed, sponsored by Eye Surgeons of Indiana.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the benefit of treatment with a physician administered intracanalicular dexamethasone insert in evaporative dry eye disease (DED) patients with meibomian gland disfunction (MGD) and underlying inflammation undergoing LipiFlow Thermal Pulsation.
Conditions Studied
Interventions
- PROCEDURE LipiFlow Thermal Pulsation
- DRUG Dexamethasone Intracanalicular Insert, 0.4mg with LipiFlow Thermal Pulsation
Study Locations (1)
Indiana
- Eye Surgeons of Indiana - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2021-07-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04413279
The ClinicalTrials.gov registry entry for NCT04413279 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 413-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (95% lower). The listed sponsor is Eye Surgeons of Indiana, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dry Eye Syndromes appearing as the primary indexed condition, and to 2 interventions - of which LipiFlow Thermal Pulsation is the first listed.
NCT04413279 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT04413279 about?
NCT04413279 is a clinical study titled "Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease". To evaluate the benefit of treatment with a physician administered intracanalicular dexamethasone insert in evaporative dry eye disease (DED) patients with meibomian gland disfunction (MGD) and underlying inflammation undergoing LipiFlow Thermal Pulsation.
What is the current status of trial NCT04413279?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2020-08-01. Estimated completion is 2021-07-01.
What conditions does trial NCT04413279 study?
This clinical trial studies the following conditions: Dry Eye Syndromes.
What interventions are being tested in trial NCT04413279?
The interventions under investigation include: LipiFlow Thermal Pulsation (PROCEDURE), Dexamethasone Intracanalicular Insert, 0.4mg with LipiFlow Thermal Pulsation (DRUG).
Who is sponsoring clinical trial NCT04413279?
This trial is sponsored by Eye Surgeons of Indiana, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04413279 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ACCURATE Study for Subjects With Dry Eyes
COMPLETED · Phase 4
-
Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®
COMPLETED · Phase 4
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
ACTIVE NOT RECRUITING · NA
-
Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation
COMPLETED · NA
-
TrueTear in Sjogren's Disease Patients
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.